KINEVAC 5 ug/5mL

KINEVAC 5 ug/5mL is a lyophilized powder for solution, containing sincalide, used for diagnostic purposes. This intravenous injection is manufactured by Bracco Diagnostics Inc. in the USA.

KINEVAC 5 ug/5mL is primarily used in medical diagnostics to stimulate gallbladder contraction and bile flow. It is often employed in imaging studies to assess gallbladder function and biliary tract health. Sincalide, the active ingredient, is a synthetic version of a hormone that naturally occurs in the body, aiding in the evaluation of digestive system disorders.

When administered intravenously, KINEVAC 5 ug/5mL can induce gallbladder contraction, which may lead to temporary discomfort or pain in the abdominal area. Some individuals might experience nausea or vomiting as a response to the stimulation of bile flow. These effects are generally short-lived and subside once the diagnostic procedure is complete.

KINEVAC 5 ug/5mL should be handled with care, ensuring proper storage and preparation before administration. It is crucial to follow medical guidelines for reconstitution and dosage to avoid any adverse reactions. Patients with known allergies to sincalide or any components of the solution should avoid its use.

KINEVAC 5 ug/5mL may interact with other medications that affect bile flow or gallbladder function. It is important to inform healthcare providers about all current medications to prevent potential interactions. Alcohol and certain foods might also influence the effectiveness of the diagnostic procedure, so specific dietary restrictions may be advised.